Project description
Disease-modifying therapies for neurodegenerative disorders
Mechanobiology examines how physical forces influence cell physiology. It may connect multiple neurodegenerative diseases through mechanisms like cytoskeletal changes and protein aggregation. With the support of the Marie Skłodowska-Curie Actions programme, the NEUROMECH project aims to develop disease-modifying therapies for Alzheimer's, Parkinson's, frontotemporal dementia, and amyotrophic lateral sclerosis. It will train a new generation of innovative scientific leaders by integrating mechanobiology with neurodegenerative disease research. The programme will employ various advanced techniques, from atomic force microscopy to in vivo investigations using magnetic resonance imaging. With participation from industrial partners and a top European business school, candidates will receive training in managerial and strategic skills, helping them to navigate the complex landscape of neurodegenerative research.
Objective
NEUROMECH aims to establish a new generation of skilled, entrepreneurial, and innovative scientific leaders that will integrate the currently isolated fields of mechanobiology and neurodegenerative diseases.
Mechanobiology explores the effects of physical forces on cell physiology. Evidence indicates that key mechanisms of neurodegeneration – cytoskeletal alterations, protein aggregation, protein phase transitions, DNA damage accumulation, and metabolic alterations – can be a consequence and cause of mechanical alterations. Mechanobiology may therefore be a unifying process in a broad spectrum of neurodegenerative diseases, which have rarely been approached from the mechanobiology prospective. NEUROMECH will bridge this gap and address the need for disease modifying therapies focusing on Alzheimer's and Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis.
NEUROMECH is an international and synergistic network of key scientific experts in mechanobiology and neurodegenerative diseases. Its ambitious research program ranges from atomic force microscopy to in vivo investigations using magnetic resonance imaging. The consortium includes industrial partners and a top European business school to provide training on managerial and strategic skills. These tools will allow Doctoral Candidates to fully understand and navigate both the complex landscape of neurodegenerative diseases research and the value chain of the very different organizations operating in this domain.
Overall, NEUROMECH will provide Doctoral Candidates with multidisciplinary, intersectoral training that will enhance their career perspectives in academic and non-academic sectors.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral Networks
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-MSCA-2024-DN-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
67100 L AQUILA
Italy
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.